10 Best Promising Stocks For 2015

10 Best Promising Stocks For 2015: XOMA Ltd.(XOMA)

XOMA Ltd., a biopharmaceutical company, engages in the discovery, development, and manufacture of therapeutic antibodies to treat autoimmune, infectious, inflammatory, and oncological diseases. Its products under development include gevokizumab, an anti-inflammatory monoclonal antibody that inhibits interleukin-1 beta and has completed Phase 2 development stage for the treatment of Behcet?s uveitis, as well as is in Phase 2b clinical trail for Type 2 diabetes with cardiovascular biomarkers; XOMA 3AB, a biodefense anti-botulism product candidate comprising a combination or cocktail of antibodies for the treatment of botulism poisoning; and preclinical antibody discovery programs in various indications, including autoimmune, cardio-metabolic, inflammatory, and oncological diseases. The company, through its collaboration agreement with Novartis AG, is also developing HCD122, a human anti-CD40 antagonist antibody that is in Phase 1/2 clinical trial for the treatment of B-cell mediated diseases, including malignancies and autoimmune diseases; and LFA102, which is in Phase 2 clinical trial for the treatment of hematologic tumors and other undisclosed diseases. In addition, it licenses proprietary technologies relating to bacterial expression of recombinant pharmaceutical products to biotechnology and pharmaceutical companies. The company has collaboration agreements with Les Laboratoires Servier; National Institute of Allergy and Infectious Diseases; SRI International; Takeda Pharmaceutical Company Limited; Novartis AG; Arana Therapeutics Limited; Kaketsuken; Genentech, Inc.; and UCB Celltech. XOMA Ltd. was founded in 1981 and is headquartered in Berkeley, California.

Advisors' Opinion:

• [By Lisa Levin]

  XOMA (NASDAQ: XOMA) shares gained 7.55% to $4.70 in the pre-market session on encouraging Phase 2 Gevokizumab results.

  Central European Media Enterprises (NASDAQ: CETV) soared 5.67% to $2.98 in the pre-ma! rket trading. Central European Media shares have tumbled 48.07% over the past 52 weeks, while the S&P 500 index has gained 23.52% in the same period.

• [By Keith Speights]

  Good omen
  Xoma Pharmaceuticals (NASDAQ: XOMA  ) reported first-quarter results on Wednesday. The company announced lower revenue compared with the same period last year, but the market didn't care. Shares surged nearly 19% on other news from Xoma.

source from Top Penny Stocks For 2015:http://www.topstocksforum.com/10-best-promising-stocks-for-2015-3.html